Lsv Asset Management United Therapeutics Corp Transaction History

Lsv Asset Management

  • $41.9 Billion
  • Q2 2025

A detailed history of Lsv Asset Management transactions in United Therapeutics Corp stock. As of the latest transaction made, Lsv Asset Management holds 864,623 shares of UTHR stock, worth $349 Million. This represents 0.59% of its overall portfolio holdings.

Number of Shares
864,623
Previous 902,323 4.18%
Holding current value
$349 Million
Previous $278 Million 10.68%
% of portfolio
0.59%
Previous 0.67%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 11, 2025
SELL
$276.47 - $328.4 $10.4 Million - $12.4 Million
-37,700 Reduced 4.18%
864,623 $248 Million
Q1 2025

May 08, 2025
SELL
$304.42 - $380.78 $1.95 Million - $2.44 Million
-6,401 Reduced 0.7%
902,323 $278 Million
Q4 2024

Feb 13, 2025
SELL
$348.66 - $410.0 $21.2 Million - $24.9 Million
-60,741 Reduced 6.27%
908,724 $321 Million
Q3 2024

Nov 12, 2024
BUY
$311.04 - $363.55 $962,668 - $1.13 Million
3,095 Added 0.32%
969,465 $347 Million
Q2 2024

Aug 06, 2024
BUY
$228.26 - $319.04 $99.7 Million - $139 Million
436,851 Added 82.5%
966,370 $308 Million
Q1 2024

May 06, 2024
BUY
$210.76 - $249.51 $32.1 Million - $38 Million
152,151 Added 40.32%
529,519 $122 Million
Q4 2023

Feb 06, 2024
SELL
$214.88 - $256.94 $1.22 Million - $1.46 Million
-5,700 Reduced 1.49%
377,368 $83 Million
Q3 2023

Nov 03, 2023
BUY
$211.82 - $248.24 $783,734 - $918,488
3,700 Added 0.98%
383,068 $86.5 Million
Q2 2023

Aug 02, 2023
SELL
$205.19 - $232.99 $3.87 Million - $4.39 Million
-18,840 Reduced 4.73%
379,368 $83.7 Million
Q1 2023

May 02, 2023
SELL
$212.99 - $276.17 $2.94 Million - $3.81 Million
-13,810 Reduced 3.35%
398,208 $89.2 Million
Q4 2022

Feb 08, 2023
SELL
$205.95 - $280.43 $31.6 Million - $43 Million
-153,504 Reduced 27.14%
412,018 $115 Million
Q3 2022

Nov 07, 2022
SELL
$203.3 - $244.17 $5.27 Million - $6.32 Million
-25,900 Reduced 4.38%
565,522 $118 Million
Q2 2022

Aug 10, 2022
SELL
$174.81 - $241.14 $520,933 - $718,597
-2,980 Reduced 0.5%
591,422 $139 Million
Q1 2022

May 12, 2022
BUY
$166.16 - $213.96 $9.53 Million - $12.3 Million
57,350 Added 10.68%
594,402 $107 Million
Q4 2021

Jan 28, 2022
BUY
$184.32 - $216.08 $2.35 Million - $2.76 Million
12,766 Added 2.43%
537,052 $116 Million
Q3 2021

Nov 04, 2021
SELL
$179.86 - $214.88 $5.28 Million - $6.3 Million
-29,340 Reduced 5.3%
524,286 $96.8 Million
Q2 2021

Aug 04, 2021
SELL
$170.47 - $211.93 $3.37 Million - $4.19 Million
-19,770 Reduced 3.45%
553,626 $99.3 Million
Q1 2021

Apr 30, 2021
SELL
$153.94 - $174.85 $3.91 Million - $4.44 Million
-25,420 Reduced 4.25%
573,396 $95.9 Million
Q4 2020

Feb 08, 2021
BUY
$101.87 - $151.79 $4.16 Million - $6.2 Million
40,860 Added 7.32%
598,816 $90.9 Million
Q3 2020

Oct 23, 2020
BUY
$99.9 - $121.13 $3.99 Million - $4.84 Million
39,922 Added 7.71%
557,956 $56.4 Million
Q2 2020

Aug 05, 2020
BUY
$92.74 - $125.82 $16.3 Million - $22.1 Million
175,287 Added 51.14%
518,034 $62.7 Million
Q1 2020

May 07, 2020
BUY
$79.39 - $115.35 $11.6 Million - $16.9 Million
146,354 Added 74.52%
342,747 $32.5 Million
Q4 2019

Feb 10, 2020
BUY
$78.31 - $95.34 $5.29 Million - $6.44 Million
67,534 Added 52.41%
196,393 $17.3 Million
Q3 2019

Nov 07, 2019
SELL
$74.85 - $85.99 $6.35 Million - $7.3 Million
-84,893 Reduced 39.72%
128,859 $10.3 Million
Q2 2019

Aug 08, 2019
SELL
$76.06 - $120.81 $24.1 Million - $38.4 Million
-317,463 Reduced 59.76%
213,752 $16.7 Million
Q1 2019

May 07, 2019
SELL
$107.15 - $126.84 $9.14 Million - $10.8 Million
-85,334 Reduced 13.84%
531,215 $62.3 Million
Q4 2018

Feb 05, 2019
BUY
$101.4 - $128.73 $10.8 Million - $13.7 Million
106,460 Added 20.87%
616,549 $67.1 Million
Q3 2018

Nov 06, 2018
BUY
$113.81 - $129.46 $3.37 Million - $3.83 Million
29,600 Added 6.16%
510,089 $65.2 Million
Q2 2018

Aug 08, 2018
BUY
$101.14 - $118.31 $6.08 Million - $7.12 Million
60,149 Added 14.31%
480,489 $54.4 Million
Q1 2018

May 04, 2018
BUY
$107.21 - $151.94 $15.7 Million - $22.2 Million
146,194 Added 53.33%
420,340 $47.2 Million
Q4 2017

Feb 01, 2018
BUY
$118.58 - $151.28 $12.2 Million - $15.5 Million
102,565 Added 59.78%
274,146 $0
Q3 2017

Nov 13, 2017
BUY
$114.6 - $136.81 $19.7 Million - $23.5 Million
171,581
171,581 $20.1 Million

Others Institutions Holding UTHR

# of Institutions
745
Shares Held
44.1M
Call Options Held
340K
Put Options Held
318K
View Full List

About UNITED THERAPEUTICS Corp

UTHR Quotes by TradingView
  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $18.4B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Lsv Asset Management Portfolio

Follow Lsv Asset Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lsv Asset Management, based on Form 13F filings with the SEC.

News

Stay updated on Lsv Asset Management with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email